BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
66.09
+0.08 (0.12%)
Nov 5, 2024, 1:19 PM EST - Market open
BioMarin Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 322.29 | 167.65 | 141.56 | -64.08 | 854.03 | -23.85 | Upgrade
|
| Depreciation & Amortization | 99.68 | 104.39 | 101.97 | 108.04 | 105.17 | 105.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10 | - | -108 | - | -52.82 | -25 | Upgrade
|
| Asset Writedown & Restructuring Costs | 38.61 | 38.61 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.07 | -9.23 | 3.04 | 5.16 | 0.57 | -2 | Upgrade
|
| Stock-Based Compensation | 204.51 | 207.1 | 196.31 | 197.26 | 189.71 | 159.87 | Upgrade
|
| Other Operating Activities | -8.2 | -12.71 | -62.6 | -7.88 | -786.36 | -64.96 | Upgrade
|
| Change in Accounts Receivable | -188.95 | -190.44 | -82.03 | 65.57 | -59.04 | -37.85 | Upgrade
|
| Change in Inventory | -88.37 | -157.06 | -68.26 | -35.06 | -61.15 | -107.55 | Upgrade
|
| Change in Accounts Payable | 80.54 | 68.85 | 59.02 | 15.69 | -87.03 | 77.09 | Upgrade
|
| Change in Other Net Operating Assets | -33.58 | -57.9 | -5.1 | 19.83 | -17.72 | -32.78 | Upgrade
|
| Operating Cash Flow | 414.7 | 159.26 | 175.9 | 304.54 | 85.37 | 48.26 | Upgrade
|
| Operating Cash Flow Growth | 199.29% | -9.46% | -42.24% | 256.75% | 76.88% | 138.83% | Upgrade
|
| Capital Expenditures | -94.81 | -96.69 | -120.96 | -95.58 | -114.31 | -145.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -9 | -10.92 | 92.74 | -23.65 | 43.95 | 6.62 | Upgrade
|
| Investment in Securities | 97.8 | -3.63 | 8.19 | -246.09 | 26.17 | 108.19 | Upgrade
|
| Other Investing Activities | 1.14 | - | - | -0.99 | -9.43 | -0.81 | Upgrade
|
| Investing Cash Flow | -4.88 | -111.24 | -20.03 | -366.31 | -53.62 | -31.03 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 585.75 | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.29 | -2.61 | -3.04 | -381.91 | -5.09 | Upgrade
|
| Net Debt Issued (Repaid) | -497.27 | -2.29 | -2.61 | -3.04 | 203.84 | -5.09 | Upgrade
|
| Issuance of Common Stock | 56.22 | 69.35 | 69.33 | 49.19 | 71.91 | 31.61 | Upgrade
|
| Repurchase of Common Stock | -76.57 | -76.32 | -54.28 | -45.81 | -94.64 | -42.68 | Upgrade
|
| Other Financing Activities | -0.84 | -9.48 | -31.1 | -0.4 | - | -58.52 | Upgrade
|
| Financing Cash Flow | -518.47 | -18.73 | -18.65 | -0.05 | 181.12 | -74.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.32 | 1.31 | 0.03 | -0.06 | -1.15 | 0.9 | Upgrade
|
| Net Cash Flow | -109.97 | 30.6 | 137.26 | -61.88 | 211.71 | -56.54 | Upgrade
|
| Free Cash Flow | 319.89 | 62.57 | 54.94 | 208.96 | -28.95 | -96.76 | Upgrade
|
| Free Cash Flow Growth | 811.36% | 13.88% | -73.71% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 11.62% | 2.59% | 2.62% | 11.32% | -1.56% | -5.68% | Upgrade
|
| Free Cash Flow Per Share | 1.66 | 0.33 | 0.29 | 1.14 | -0.15 | -0.54 | Upgrade
|
| Cash Interest Paid | 10.32 | 10.3 | 10.28 | 10.4 | 12.18 | 8.55 | Upgrade
|
| Cash Income Tax Paid | 57.71 | 73.31 | 54.37 | 18.15 | 8.98 | 9.73 | Upgrade
|
| Levered Free Cash Flow | 144.67 | -25.9 | 146.25 | 201.61 | -18.77 | -133.19 | Upgrade
|
| Unlevered Free Cash Flow | 154.79 | -15.06 | 156.23 | 211.19 | -0.45 | -118.53 | Upgrade
|
| Change in Net Working Capital | 249.59 | 326.5 | 156.93 | -71.56 | 167.62 | 179.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.